Blood Cancer News and Research

RSS
Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia

Study maps potential link between oil and gas production and childhood leukemia risk

Study maps potential link between oil and gas production and childhood leukemia risk

Blood cancer patients show widely variable response to COVID-19 vaccines

Blood cancer patients show widely variable response to COVID-19 vaccines

Researchers uncover new function of regulator protein in multiple myeloma development

Researchers uncover new function of regulator protein in multiple myeloma development

Three CU researchers recognized for contributions to immunotherapy in childhood cancer

Three CU researchers recognized for contributions to immunotherapy in childhood cancer

A World First: sequencing polyclonal antibodies using only proteomics

A World First: sequencing polyclonal antibodies using only proteomics

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Convalescent plasma can improve chances of survival among blood cancer patients with COVID-19

Convalescent plasma can improve chances of survival among blood cancer patients with COVID-19

Experimental monoclonal antibody could be a new weapon against HIV epidemic

Experimental monoclonal antibody could be a new weapon against HIV epidemic

Study could help identify risk of secondary leukaemia in certain children

Study could help identify risk of secondary leukaemia in certain children

Kinase inhibitors could provide an effective way to treat high-risk leukaemia

Kinase inhibitors could provide an effective way to treat high-risk leukaemia

Higher CD8 T cells may influence COVID-19 recovery in blood cancer patients

Higher CD8 T cells may influence COVID-19 recovery in blood cancer patients

Researchers conduct first-in-man clinical trial for new stem cell technology

Researchers conduct first-in-man clinical trial for new stem cell technology

Adults are more likely to donate to charity when children are present, shows study

Adults are more likely to donate to charity when children are present, shows study

New combination treatment could benefit T-ALL patients who do not respond to chemotherapy

New combination treatment could benefit T-ALL patients who do not respond to chemotherapy

Studies suggest mRNA COVID-19 vaccine may have reduced efficacy in patients with blood cancer

Studies suggest mRNA COVID-19 vaccine may have reduced efficacy in patients with blood cancer